Inhibition by noncompetitive nmda receptor antagonists of apomorphine-induced climbing behavior in mice

This publication has 25 references indexed in Scilit:

• Characteristics of the Ambulation-Increasing Effect of the Noncompetitive NMDA Antagonist MK-801 in Mice: Assessment by the Coadministration with Central-Acting Drugs.
  The Japanese Journal of Pharmacology, 1992
• Assessment of the Ambulation-Increasing Effect of Ketamine by Coadministration with Central-Acting Drugs in Mice.
  The Japanese Journal of Pharmacology, 1992
• Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat
  Neuroscience Letters, 1991
• The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
• demonstration of the enhancement of MK-801 by L-glutamate
  Life Sciences, 1989
• Increased sensitivity to dopamine agonists following a single dose of morphine or levorphanol in mice
  European Journal of Pharmacology, 1985
• Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: Comparisons to other psychomotor stimulants
  Psychopharmacology, 1983
• Further evidence for a motility substitution test as a tool to detect the narcotic character of new drugs in rats
  Neuropharmacology, 1983
• Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
  Drug Development Research, 1982
• Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum
  Psychopharmacology, 1976